A meta-analysis of efficacy and safety of the new α1A-adrenoceptor-selective antagonist silodosin for treating lower urinary tract symptoms associated with BPH-Reference-Cited by-同舟云学术

A meta-analysis of efficacy and safety of the new α1A-adrenoceptor-selective antagonist silodosin for treating lower urinary tract symptoms associated with BPH

Published:2012-09-18 Issue:1 Volume:16 Page:79-84
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Wu Y J,Dong Q,Liu L R,Wei Q

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/pcan201236.pdf

Reference22 articles.

1. Berry SJ, Coffey DS, Walsh PC, Edwin LL . The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474–479.

2. Chapple C . Medical treatment for benign prostatic hyperplasia. BMJ 1992; 304: 1198–1199.

3. Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN . Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 1993; 150: 351–358.

4. Andersson KE, Gratzke C . Pharmacology of α1-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat Clin Pract Urol 2007; 4: 368–378.

5. Roehrborn CG, Schwinn DA . α1-Adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia. J Urol 2004; 171: 1029–1035.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma metabolites as mediators in inflammation-related proteins - benign prostatic hyperplasia risk: insights from Mendelian randomization;2024-08-14

2. Comparative efficacy and safety of alpha-blockers as monotherapy for benign prostatic hyperplasia: a systematic review and network meta-analysis;Scientific Reports;2024-05-15

3. The effect of selective alpha-1 receptor antagonist on arterial stiffness parameters in patients with benign prostate hyperplasia;2024-02-20

4. Pharmacological Management of Ureteral Stent–related Symptoms: A Systematic Review, Bayesian Network Meta-analysis, and Meta-regression;Journal of Urology;2023-11

5. Electronic medical records-based retrospective, longitudinal, observational study to understand the patient management of benign prostatic hyperplasia with alpha-blockers monotherapy in Indian population;Urology Annals;2023